MOTS - Motus GI Holdings, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Motus GI Holdings, Inc.

1301 East Broward Boulevard
3rd Floor, Suite 310
Fort Lauderdale, FL 33301
United States

IndustryDiagnostics & Research
Full Time Employees44

Key Executives

NameTitlePayExercisedYear Born
Mr. Timothy P. MoranCEO & Director779.95kN/A1972
Mr. Mark PomeranzPres, COO & Director501.96kN/A1961
Mr. Andrew Lawrence TaylorChief Financial Officer356.54kN/A1971
Mr. Steven M. BosrockVP of Global Marketing & StrategyN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system, a medical device, which indicates to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company was founded in 2016 and is based in Fort Lauderdale, Florida.

Corporate Governance

Motus GI Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.